Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan Devos

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
World Journal of Urology|March 30, 2020
Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancerAntonino Battaglia, Gaëtan Devos, Karel Decaestecker, et al.
European Urology|September 27, 2022
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate CancerGaëtan Devos, Lorenzo Tosco, Marcella Baldewijns, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Oncology|December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Journal of Personality|June 11, 2021
Positive and negative urgency as a single coherent construct: Evidence from a large-scale network analysis in clinical and non-clinical samplesJoël Billieux, Alexandre Heeren, Lucien Rochat, et al.
BJUI Compass|December 26, 2022
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancerCarlo A Bravi, Axel Heidenreich, Nicola Fossati, et al.
European Urology|July 7, 2020
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional SeriesCarlo A Bravi, Nicola Fossati, Giorgio Gandaglia, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
World Journal of Urology|March 30, 2020
Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancerAntonino Battaglia, Gaëtan Devos, Karel Decaestecker, et al.
European Urology|September 27, 2022
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate CancerGaëtan Devos, Lorenzo Tosco, Marcella Baldewijns, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Oncology|December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Journal of Personality|June 11, 2021
Positive and negative urgency as a single coherent construct: Evidence from a large-scale network analysis in clinical and non-clinical samplesJoël Billieux, Alexandre Heeren, Lucien Rochat, et al.
BJUI Compass|December 26, 2022
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancerCarlo A Bravi, Axel Heidenreich, Nicola Fossati, et al.
European Urology|July 7, 2020
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional SeriesCarlo A Bravi, Nicola Fossati, Giorgio Gandaglia, et al.
Pageof 5